Shri Vari Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.41 M
as on 16-11-2024
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
as on 16-11-2024
- Satisfied Charges ₹ 4.90 M
as on 16-11-2024
- Revenue 21.50%
(FY 2023)
- Profit -62.30%
(FY 2023)
- Ebitda 74.20%
(FY 2023)
- Net Worth 7.58%
(FY 2023)
- Total Assets 0.29%
(FY 2023)
About Shri Vari Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.41 M.
The company currently has active open charges totaling ₹1.40 Cr. The company has closed loans amounting to ₹4.90 M, as per Ministry of Corporate Affairs (MCA) records.
Padamchand Chordia and Ajay Chordia serve as directors at the Company.
- CIN/LLPIN
U24211TN2006PTC061083
- Company No.
061083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shri Vari Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padamchand Chordia  | Director | 12-Sep-2006 | Current |
| Ajay Chordia | Director | 10-Mar-2017 | Current |
Financial Performance of Shri Vari Pharma.
Shri Vari Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.5% increase. The company also saw a substantial fall in profitability, with a 62.3% decrease in profit. The company's net worth moved up by a moderate rise of 7.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Vari Pharma?
In 2023, Shri Vari Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Aug 2023 | ₹1.40 Cr | Open |
Others Creation Date: 30 Apr 2020 | ₹1.40 M | Satisfied |
Union Bank Of India Creation Date: 01 Mar 2012 | ₹3.50 M | Satisfied |
How Many Employees Work at Shri Vari Pharma?
Unlock and access historical data on people associated with Shri Vari Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Vari Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Vari Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
